Abstract:Background The inflammatory cascade mediated by macrophages and T cells is considered to be an important factor in promoting the progression of rheumatoid arthritis (RA). Our previous study found that berberine (BBR) can therapeutically impact adjuvant arthritis (AA) in rats through the regulation of macrophage polarization and the balance of Th17/Treg. However, whether BBR's effects on CD4 + T cells response are related to its suppression of M1 macrophage still unclear. Purpose The study aimed to estimate the mechanism of BBR in regulating the immunometabolism and differentiation of CD4 + T cells are related to exosome derived from M1-macrophage (M1-exo). Study-design/methods Mice model of collagen-induced arthritis (CIA) was established to investigate the antiarthritic effect of BBR was related with regulation of M1-exo to balance T cell subsets. Bioinformatics analysis using the GEO database and meta-analysis. In vitro , we established the co-culture system involving M1-exo and CD4 + T cells to examine whether BBR inhibits CD4 + T cell activation and differentiation by influencing M1-exo-miR155. Exosome was characterized using transmission electron microscopy and western blot analysis, macrophage and CD4 + T cell subpopulation were detected by flow cytometry. Further, the metabolic profiles of CD4 + T cells were assessed by ECAR, OCR, and the level of glucose, lactate, intracellular ATP. Result BBR reinstates CD4 + T cell homeostasis and reduces miR155 levels in both M1-exo and CD4 + T cells obtained from mice with CIA. In vitro, we found exosomes are indispensable for M1-CM on T lymphocyte activation and differentiation. BBR reversed M1-exo facilitating the activation and differentiation of CD4 + T cells. Furthermore, BBR reversed glycolysis reprogramming of CD4 + T cells induced by M1-exo, while these regulation effects were significantly weakened by miR155 mimic. Conclusion The delivery of miR-155 by M1-exo contributes to CD4 + T cell immunometabolism dysfunction, a process implicated in the development of RA. The anti-arthritic effect of BBR is associated with the suppression of glycolysis and the disruption of CD4 + T cell subsets balance, achieved by reducing the transfer of M1-exo-miR155 into T cells.

Engineering M2 macrophage-derived exosomes modulate activated T cell cuproptosis to promote immune tolerance in rheumatoid arthritis

M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization

A Targeted Exosome Therapeutic Confers Both Cfdna Scavenging and Macrophage Polarization for Ameliorating Rheumatoid Arthritis

Engineering Efferocytosis‐Mimicking Nanovesicles to Regulate Joint Anti‐Inflammation and Peripheral Immunosuppression for Rheumatoid Arthritis Therapy

Reestablish immune tolerance in rheumatoid arthritis

Macrophage membrane-camouflaged biomimetic nanoparticles for rheumatoid arthritis treatment via modulating macrophage polarization

Ultrasound-augmented anti-inflammatory exosomes for targeted therapy in rheumatoid arthritis

Study of the mechanism of fibroblast-like synoviocytes-derived exosomes inducing macrophages M1 polarization and CD8+T cells immune regulation ferroptosis and autophagy in rheumatoid arthritis

Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy

The nanozymes of protein nanotubes-constructed microspheres with dual peroxidase- and catalase-like properties for M1-to-M2 macrophages repolarization and the synergistic anti-rheumatoid arthritis effect with loaded capsaicin

Cell penetrating peptide modified M2 macrophage derived exosomes treat spinal cord injury and rheumatoid arthritis by loading curcumin

Engineered M2a macrophages for the treatment of osteoarthritis

Autoantigenic Peptide and Immunomodulator Codelivery System for Rheumatoid Arthritis Treatment by Reestablishing Immune Tolerance

Transdermal Microneedles Alleviated Rheumatoid Arthritis by Inducing Immune Tolerance via Skin‐Resident Antigen Presenting Cells

Macrophage Membrane-Reversibly Cloaked Nanotherapeutics for the Anti-Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis

Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms

Human umbilical mesenchymal stem cell-derived exosomes alleviate bone destruction and regulate bone immunity via the aryl hydrocarbon receptor to treat rheumatoid arthritis

Berberine modulates the immunometabolism and differentiation of CD4 + T cells alleviating experimental arthritis by suppression of M1-exo-miR155

Biomimetic and inflammation-targeted nanoparticles for rheumatoid arthritis therapy via M1-macrophages apoptosis and polarization

Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles.

Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage